image_7

The 4th Microbiome R&D and Business Collaboration Forum: USA

RSS de esta página

La Jolla, San Diego, California, 03/10/2016 - 04/10/2016

Imagen Evento

Recent research has demonstrated the importance of our microbes in our maintaining health and their possible use in treating and preventing disease. As microbial dysbiosis has been shown to be linked to several long-term diseases; approaches that modify our microbiome by adding or removing individual microbes or entire microbial communities have been shown to have a significant impact on the health of an individual. This potential to use the microbiome as a therapy and to design treatments customised to the patient’s microbiome has created a rapidly growing interest from the pharmaceutical industry and investors and it looks set to continue to grow in the coming years with the emerging microbiome market expected to reach US$658 million by 2023. There is a rich source of information, backing and partnering opportunities for researchers and companies looking for opportunities in this field

The 2-day congress will examine a range of topics including:

  • Host-microbe interactions
  • Microbiome in health and disease
  • Pharmaceutical involvement and translational microbiome studies
  • Venture capital investment and collaborations
  • Probiotics, prebiotics, diet and the microbiome
  • Skin, respiratory, vaginal and oral microbiota research and therapeutic development
  • Co-located probiotics congress

+ info

Contributor

Eduardo Pareja